Centella Mauritius Holdings Limited has corrected the reported size of its holding in Aster DM Quality Care Limited from 9.7% to 9.9%. The difference is only 0.2 percentage points, but the correction matters because shareholding figures form part of the public record and can affect the way investors read later transactions.
The corrected figure is supported by shareholding data that shows Centella with 8.63 crore shares, equal to 9.9% of Aster DM Quality Care. A separate market report also states that Centella held 9.9% as of July 23, 2026.
This article uses the corrected 9.9% figure. It also separates confirmed facts from matters that remain subject to exchange disclosures. That distinction is important because a report about a possible sale should not, by itself, be treated as proof that every part of a transaction has closed.
What is confirmed
Aster DM Quality Care is the name of the company after the merger of Aster DM Healthcare and Quality Care India Limited. The merger formed a larger listed healthcare company. The transaction also changed the shareholding structure of the combined entity.
The Competition Commission of India had approved the transaction in April 2025. The approved structure included a share acquisition by Aster from BCP Asia and Centella before the merger. The official regulatory record also said that Centella would hold less than 10% in the merged company and would have no control rights.
Aster later confirmed the completion of a 5% acquisition in Quality Care India through a share swap. The company said that it acquired 1,90,46,028 Quality Care shares from BCP and Centella for a value of ₹849.13 crore. Aster then allotted 1,86,07,969 equity shares to BCP and Centella as part of the consideration.
These steps help explain why Centella became a material shareholder of the enlarged Aster entity.
| Item | Confirmed figure or fact |
|---|---|
| Corrected Centella holding | 9.9% |
| Centella shares | 8.63 crore |
| Reported proposed sale | 7.2% |
| Reported floor price | ₹766.10 per share |
| Reported value of proposed sale | About ₹4,780 crore |
| Shares in later block deals | 5.86 crore |
| Equity represented by later block deals | 11.3% |
| Reported block-deal price | ₹769.80 per share |
The figures above come from public shareholding data and market reports. They should not be read as one single transaction unless the relevant exchange filings confirm that position.
The proposed 7.2% sale
On August 18, 2026, CNBC-TV18 reported that Centella Mauritius Holdings was likely to sell 7.2% of Aster DM Quality Care through a block deal. The report placed the value at about ₹4,780 crore and stated that the floor price was ₹766.10 per share.
The next day, August 19, a block deal involved 5.86 crore shares, or 11.3% of Aster’s equity, at about ₹769.80 per share. The report stated that the official buyers and sellers were not yet known at that point.
This creates an important point for readers. The reported 7.2% proposed sale and the later 11.3% block-deal volume are not the same figure. It would therefore be unsafe to state that the full 11.3% block-deal volume came from Centella without a clear exchange disclosure that confirms the seller.
The same caution applies to the identity of buyers. A block deal tells the market that a large quantity of shares changed hands under the relevant trading mechanism. It does not, by itself, establish the identity of every buyer or seller.
What the 9.9% figure tells us
The 9.9% figure places Centella just below the 10% level. That is relevant from a disclosure and ownership perspective, but the number alone does not establish control.
The regulatory record for the Aster-Quality Care transaction stated that Centella would hold less than 10% in the merged entity and would have no control rights.
This means the most careful way to describe Centella is as a substantial shareholder, rather than as a controlling shareholder.
There is also a useful distinction between a shareholder’s economic interest and control. A holder can own a large percentage of a listed company without having control over the company’s board, management, or business decisions. Control depends on the legal rights attached to the shares, shareholder agreements, board rights, voting arrangements, and other relevant facts.
No conclusion about control should therefore arise from the 9.9% number alone.
What could remain after the proposed sale
If Centella held 9.9% and sold exactly 7.2 percentage points of Aster’s total equity, the simple arithmetic would leave about 2.7%.
That is only an arithmetic illustration. It should not be treated as the final post-sale shareholding until the relevant exchange filings confirm the actual number of shares sold and the final position of Centella.
| Scenario | Percentage |
| Corrected reported holding | 9.9% |
| Reported proposed disposal | 7.2% |
| Simple residual calculation | About 2.7% |
The distinction is important because market reports can describe a proposed transaction before the final settlement and regulatory disclosure. The final number can differ if the transaction size, allocation, or settlement terms differ.
Why the transaction has market importance
A sale of this size can matter to the market for several reasons.
First, a large shareholder sale can increase the number of shares available to other investors. This can improve the free float over time, depending on the final ownership structure.
Second, the price at which a large block changes hands can become a reference point for market participants. The reported floor price of ₹766.10 and the reported block-deal price of ₹769.80 are close to each other. However, a block price should not be treated as a fair value estimate for the company.
Third, the identity and nature of the buyer can matter. A long-term institutional buyer may send a different market signal from a short-term investor. Until the buyer is formally identified, it is better not to assign a motive to the transaction.
Fourth, the transaction can alter the ownership balance between promoters, strategic shareholders, institutions and other public investors.
The wider promoter structure
Public shareholding data for July 2026 shows promoter and promoter-group ownership at about 53.72%, while public shareholders held about 46.28%. The same data shows Centella with 9.9% and BCP Asia II TopCo IV Pte. Ltd. with about 29.71%.
There is an important detail here. Some sources describe Centella as a public shareholder in the exchange shareholding classification, while the broader transaction history connects Centella with TPG-related investment interests. The legal classification used in a stock exchange filing should take priority over a casual description in a news article.
The July shareholding data also shows that promoter holdings had increased to 53.72% from 40.39% in the prior period. That change must be read in the context of the merger and related share issuance rather than treated as a simple market purchase.
The role of the Aster-Quality Care merger
The merger is central to the ownership story.
Aster DM Healthcare and Quality Care India combined their businesses under the approved merger structure. Aster’s official investor material lists the merger scheme, NCLT orders, shareholder voting records and other related documents. The company later operated under the name Aster DM Quality Care Limited.
Before the merger, BCP Asia, Centella and other investors had interests in Quality Care India. The transaction structure gave these investors shares in the enlarged Aster entity.
This explains why an investor who held an interest in Quality Care India could later appear as a shareholder of Aster DM Quality Care. The post-merger share count is therefore important when a person compares old and new percentage holdings.
A percentage cannot always be compared across two periods without first checking the total number of shares in each period.
What investors should not assume
The corrected 9.9% figure does not, by itself, prove that Centella wants to exit Aster completely.
The reported 7.2% sale does not, by itself, prove that Centella has no further interest in the company.
The reported block deal of 11.3% does not, by itself, prove that Centella sold the full amount.
The block-deal price of ₹769.80 does not, by itself, establish the intrinsic value of Aster DM Quality Care.
The presence of a large seller does not, by itself, prove that the seller has a negative view of the company.
These distinctions are important because large institutional transactions can arise from many reasons. Portfolio rebalancing, fund life, liquidity needs, ownership limits, asset allocation, or other commercial factors can all affect a shareholder’s decision. Unless the shareholder states the reason, it would be speculative to assign one.
The legal and disclosure angle
For a listed company, shareholding changes are subject to securities law and stock exchange disclosure rules. The exact disclosure requirement can depend on the size of the holding, the nature of the transaction, the status of the shareholder and the relevant regulatory framework.
The safest approach is therefore to rely on the company’s exchange filings for the final transaction details.
A news report can provide an early indication. It is not necessarily the final legal record of the transaction.
The same principle applies to the 9.9% correction. The corrected figure is supported by current shareholding data, but readers should still use the latest exchange filing when they need a legally definitive position.
A simple reading of the numbers
The core facts can be reduced to a simple sequence.
Centella’s reported position is 9.9%. A report then stated that Centella was likely to sell 7.2% at a floor price of ₹766.10 per share, with a reported transaction value of about ₹4,780 crore. On August 19, a separate block-deal report stated that 5.86 crore shares, equal to 11.3% of the company, changed hands at about ₹769.80 per share. The identities of the buyers and sellers were not yet confirmed in that report.
If the 7.2% disposal is completed exactly as reported, a simple calculation suggests that Centella could retain about 2.7%. But that is an estimate until the final filing confirms the actual post-transaction position.
| Question | Careful answer |
| What is Centella’s corrected holding? | 9.9% |
| Was a 7.2% sale reported? | Yes, as a proposed block transaction |
| What was the reported floor price? | ₹766.10 |
| What was the reported value? | About ₹4,780 crore |
| Did 11.3% of Aster trade in block deals? | Yes, as reported on August 19 |
| Was Centella confirmed as the seller of all 11.3%? | Not on the cited report |
| What could remain after a 7.2% sale from 9.9%? | About 2.7%, subject to final disclosure |
What matters next
The next useful information is the final exchange disclosure on the sale. That should help establish the exact number of shares sold by Centella, the post-sale holding, and, where required, the identity or classification of the relevant parties.
The market may also focus on the buyer of the block. A large institutional purchase could alter the ownership profile and may become relevant to future shareholding analysis.
Investors may also wish to compare the transaction price with Aster DM Quality Care’s operating results, valuation, debt position, cash generation and future business plans. A block transaction alone is not enough to judge whether the company is cheap or expensive.
The company’s June 2026 results provide another part of that picture. Public financial data shows consolidated revenue of about ₹1,310.68 crore for the quarter, compared with ₹1,077.87 crore a year earlier. Operating profit before depreciation, interest and tax, excluding other income, was reported at ₹264.32 crore, compared with ₹207.36 crore in the prior-year quarter.
Those numbers suggest that the ownership event should be viewed beside the underlying business results rather than in isolation.
Final assessment
The correction from 9.7% to 9.9% is small in percentage terms, but it gives a clearer picture of Centella’s actual position in Aster DM Quality Care.
The most reliable current reading is that Centella held 9.9%, equal to about 8.63 crore shares, before the reported disposal. A proposed sale of 7.2% was reported at a floor price of ₹766.10 per share, with an estimated value of about ₹4,780 crore. A later report confirmed that 5.86 crore shares, or 11.3% of Aster, changed hands at about ₹769.80 per share, but it did not identify all buyers and sellers at that stage.
The most reasonable conclusion is therefore limited but useful: Centella had a material 9.9% economic interest, a substantial sale was reported, and the final post-sale position should be confirmed from the exchange record.
It would be too strong to say that the transaction proves a lack of confidence in Aster. It would also be too strong to say that the transaction has no effect on the company’s ownership profile.
For investors, the key point is simple. The corrected 9.9% number should be used for the ownership analysis, while the final exchange disclosures should be used to confirm the exact result of the reported sale.
This article is for general information and analysis. It does not state or imply any fact beyond the cited public information, and it is not legal, tax, accounting or investment advice. Any conclusion about a shareholder’s motive, control, future sale, or investment view should be avoided unless supported by a formal disclosure or other reliable evidence.
ALSO READ: India PMI Shows a Mixed Growth Path in August 2026
